Cet anticorps anti-VEGF-Apan (Peptide) Polyclonal Lapin (ABIN1589724) détecte spécifiquement VEGF-Apan (Peptide) dans IP et WB.
L’anticorps est réactif avec des échantillons de Humain.
Aperçu rapide pour VEGF-Apan (Peptide) (N-Term) anticorps (ABIN1589724)
Antigène
VEGF-Apan (Peptide)
Reactivité
Humain
Hôte
Lapin
Clonalité
Polyclonal
Application
Immunoprecipitation (IP), Western Blotting (WB)
Épitope
N-Term
Fonction
VEGF-Apan (Peptide) antibody
Specificité
N-terminal peptide (20aa) of native human VEGF165
Attributs du produit
Chromosomal location: 6p12 Produced from sera of rabbits immunized with a highly purified N-terminal peptide of human VEGF-A.
Purification
Anti-VEGF-A was purified by affinity chromatography with immobilized Protein A.
Immunogène
N-terminal peptide (20aa) of native human VEGF165
Isotype
IgG
Indications d'application
IP: Use 1-5 μg/mL
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
Buffer
PBS
Conseil sur la manipulation
Centrifuge vial prior to opening.
Stock
4 °C,-20 °C
Stockage commentaire
The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
Date de péremption
24 months
Antigène
VEGF-Apan (Peptide)
Sujet
VEGFA, VPF, VEGF, MVCD1,Vascular endothelial growth factor (VEGF or VEGF-A), also known as vascular permeability factor (VPF) or vasculotropin, is a homodimeric 34 - 42 kDa, heparin-binding glycoprotein with potent angiogenic, mitogenic and vascular permeability-enhancing activities specific for endothelial cells. Different isoforms can be generated by differential splicing (e.g. VEGF165). All eight cysteine residues involved in intra- and inter-chain disulfide bonds are conserved among these growth factors. A cDNA encoding a protein having a 53 % amino acid sequence homology in the PDGF-like region of VEGF has been isolated from a human placental cDNA library. This protein, named placenta growth factor (PlGF), is now recognized to be a member of the VEGF family of growth factors. Two receptor tyrosine kinases have been described as putative VEGF receptors. Flt-1 (fms-like tyrosine kinase), and KDR (kinase-insert-domain-containing receptor) proteins have been shown to bind VEGF-A with high affinity. In vitro, VEGF is a potent endothelial cell mitogen. The antibody is against the N-terminus and will recognize all VEGF-A isoforms.